Latest filing published 03 Apr 2017 for Cipher Pharmaceuticals Inc..
No signal scores available.
Peter John Weiler appears in our data through filings on Cipher Pharmaceuticals Inc. shares, published by SEDI. In total, 3 filings cover trades dated from 15 March 2016 to 15 March 2017.
Sales make up the whole of the open-market record (1 sale). The amount is not disclosed for 1 filing. The rest of the record consists of 2 option exercises.
The latest filing, published on 3 April 2017, reports an option exercise in Cipher Pharmaceuticals Inc. Between a trade and the moment it shows up on SEDI, the median delay is 5 days. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations